SequelSEC

HEALTHY EXTRACTS INC. HYEX

Medicinal Chemicals & Botanical Products · CIK 0001630176 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$6.29M
Fiscal year ended 2026-06-30
Operating income
Unavailable
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

HEALTHY EXTRACTS INC. (HYEX) reported revenue of $6.29M and net income of -$879.36K for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from HEALTHY EXTRACTS INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Medicinal Chemicals & Botanical Products.

Income

HEALTHY EXTRACTS INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$6.29M
Cost of revenue$2.44M
Gross profit$3.85M
Operating incomeUnavailable
Net income-$879.36K
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expense$0
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$4.95M
Selling & marketingUnavailable

Balance

HEALTHY EXTRACTS INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalentsUnavailable
Total assets$32.61M
Current assets$1.68M
Total liabilities$10.17M
Current liabilities$8.39M
Total equity incl. NCI$22.44M
Temporary (mezzanine) equityUnavailable
Inventory$644.11K
Accounts receivable$607.02K
Goodwill$26.06M
Long-term debtUnavailable
Accounts payable$340.52K

Cash flow

HEALTHY EXTRACTS INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$500.27K
Capital expendituresUnavailable
Investing cash flow$171.57K
Financing cash flow-$682.38K
Net change in cash-$10.54K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

HEALTHY EXTRACTS INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin61.1%
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.20x
Revenue YoY growth84.1%
Net margin-14.0%
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HYEX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-04-09View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

AAWH ADIA AIBT BTMD CBDY CFOO CGC CHUC CRON CYAN DFTX FTLF

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.